Actinium Pharmaceuticals
ATNM
#10501
Rank
NZ$46.97 M
Marketcap
NZ$1.50
Share price
1.42%
Change (1 day)
-48.01%
Change (1 year)

Actinium Pharmaceuticals (ATNM) - Total liabilities

Total liabilities on the balance sheet as of March 2026 : NZ$74.53 Million

According to Actinium Pharmaceuticals's latest financial reports the company's total liabilities are NZ$74.53 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Actinium Pharmaceuticals - Total liabilities on balance sheet (from 2006 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-12-31NZ$75.87 M-3.06%
2024-12-31NZ$78.26 M9.83%
2023-12-31NZ$71.26 M-5.17%
2022-12-31NZ$75.14 M650.09%
2021-12-31NZ$10.01 M42.35%
2020-12-31NZ$7.03 M-21.34%
2019-12-31NZ$8.94 M-1.23%
2018-12-31NZ$9.05 M37.89%
2017-12-31NZ$6.56 M0.67%
2016-12-31NZ$6.52 M-3.19%
2015-12-31NZ$6.74 M-44.36%
2014-12-31NZ$12.11 M35.9%
2013-12-31NZ$8.91 M57.93%
2012-12-31NZ$5.64 M-15.42%
2011-12-31NZ$6.67 M5332.86%
2010-12-31NZ$0.12 M-9.34%
2009-12-31NZ$0.13 M3.22%
2008-12-31NZ$0.13 M123.29%
2007-12-31NZ$0.05 M119.49%
2006-12-31NZ$0.02 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Genocea Biosciences
GNCA
NZ$45.62 M-38.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
NZ$1.16 B 1,466.35%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
NZ$4.11 B 5,415.16%๐Ÿ‡บ๐Ÿ‡ธ USA